CDAKQ
CODIAK BIOSCIENCES INC
stock OTC

codiak is the leader in the emerging field of exosome therapeutics, working to harness the power of this cellular messenger system to create potentially life-changing medicines. a venture-backed startup founded in 2015, codiak has rapidly built a proprietary technology platform for exosome engineering and manufacturing that allows for precise targeting of important molecular pathways, opening the door to the development of therapies for cancer and other diseases. led by an experienced and dedicated team, codiak has at its foundation a positive and collaborative culture that is deeply rooted in cutting edge science and promotes opportunity for growth. recent discoveries have transformed our understanding of the role of exosomes in the body. we now know that these natural, cell-derived vesicles can act as a potent and safe delivery system for multiple therapeutic payloads. recognizing the enormous potential of exosomes, codiak is applying leading-edge translational science and rigorous d